Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17193-28-1

Post Buying Request

17193-28-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17193-28-1 Usage

Uses

1-Amino-1-cyclopentanecarboxamide is a useful synthesis intermediate. An amino-cyclopentanecarboxamide derivative with pharmacological and tumor inhibiting activity.

Check Digit Verification of cas no

The CAS Registry Mumber 17193-28-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,9 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17193-28:
(7*1)+(6*7)+(5*1)+(4*9)+(3*3)+(2*2)+(1*8)=111
111 % 10 = 1
So 17193-28-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H12N2O/c7-5(9)6(8)3-1-2-4-6/h1-4,8H2,(H2,7,9)

17193-28-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-aminocyclopentane-1-carboxamide

1.2 Other means of identification

Product number -
Other names 1-aminocyclopentan-1-carboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17193-28-1 SDS

17193-28-1Relevant articles and documents

Original loading and Suzuki conditions for the solid-phase synthesis of biphenyltetrazoles. Application to the first solid-phase synthesis of irbesartan

Cousaert, Nicolas,Willand, Nicolas,Gesquière, Jean-Claude,Tartar, André,Déprez, Beno?t,Deprez-Poulain, Rebecca

, p. 2743 - 2747 (2008/09/18)

Biphenyltetrazoles are recognized privileged structures. Among them, the therapeutically important class of sartans displays antagonistic activity on AT1 receptors. We have developed a method for anchoring tetrazole derivatives via the heterocycle on a hydroxylated resin using zinc triflate. New Suzuki-Miyaura cross-coupling conditions are developed for the quantitative formation of the phenyl-phenyl bond. Our straightforward synthesis scheme, starting from the conserved phenyltetrazole moiety and ending with the appending of the structurally variable moiety, is well suited to the preparation of sartans and their analogues at a laboratory scale. We thus describe here the first solid phase synthesis of irbesartan, a marketed AT1 antagonist.

Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same

-

Page column 7, (2010/02/08)

The invention relates to a novel crystalline form of irbesartan, to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.

Polypeptides. VII. Variations of the phenylalanyl position in the C-terminal tetrapeptide amide sequence of the gastrins.

Gregory,Jones,Morley

, p. 531 - 540 (2007/10/06)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17193-28-1